T Cell Depletion by Cytotoxic Elimination
1National Cancer Institute, Bethesda, Maryland
Abstract
This unit describes the complete removal of T cells from lymphocyte preparations based on the presence of the glycoprotein Thy-1 on the cell surface of T lymphocytes. As in unit 3.3, cytotoxic elimination is employed; however, Thy-1-specific antibodies are used rather than MHC class II-specific antibodies so that T cells are eliminated rather than B cells and accessory cells. Murine T cells can be further fractionated into subpopulations based on their expression of cell differentiation markers CD4 (Leu3, L3T4, T4) and CD8 (Leu2, Lyt2,3). A protocol in this unit describes removal of T cell subsets by cytotoxic elimination using CD-specific antibodies. An alternate but technically more demanding method of enriching T cell subsets is the panning procedure described in unit 3.5.
Literature Cited
| Literature Cited | |
| Ceredig, R., Lowenthal, J.N., Nabholz, M., and MacDonald, H.R. 1985. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature (Lond.) 314:98-100. | |
| Dialynas, D.P., Wilde, D.B., Marrack, P., Pierres, A., Wall, K.A., Havran, W., Otten, G., Loken, M.R., Pierres, M., Kappler, J., and Fitch, F.W. 1983. Characterization of the murine antigenic determinant designated L3T4a, recognized by monoclonal antibody GK1.5: Expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol. Rev. 74:29-58. | |
| Lake, P., Clark, E.A., Khorshidi, M., and Sunshine, G.H. 1979. Production and characterization of cytotoxic Thy-1 antibody-secreting hybrid cell lines: Detection of T cell subsets. Eur. J. Immunol. 9:875-886. | |
| Ledbetter, J.A. and Herzenberg, L.A. 1979. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:63-90. | |
| Logberg, L., Wassmer, P., and Shevach, E.M. 1985. Role of the L3T4 antigen in T cell activation. I. Description of a monoclonal IgM antibody to a distinct epitope (L3T4b) of the L3T4 antigen and its effect on interleukin-2 induced thymocyte proliferation. Cell. Immunol. 94:299-311. | |
| Marshak-Rothstein, A., Fink, P., Gridley, T., Raulet, D.H., Beven, M.J., and Gefter, M.L. 1979. Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus. J. Immunol. 122:2491-2499. | |
| Sarmiento, M., Glasebrook, A.L., and Fitch, F. 1980. IgG or IgM monoclonal antibodies reactive to different determinant on the molecular complex bearing Lyt2 antigen block T cell mediated cytolysis in the absence of complement. J. Immunol. 125:2665-2672. | |
| Shen, F.W. 1981. Monoclonal antibodies and T cell hybridomas. Res. Monogr. Immunol. 3:25-37. | |
| Key References | |
| Dialynas et al., 1983. See above. | |
| Pierres, A., Naquet, P., Agthoven, A.V., Bekkahoucha, F., Denzot, D., Mishal, Z., Schmitt-Verhulst, A.M., and Pierres, M. 1984. A rat anti-mouse monoclonal antibody (H1 29-19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4 | |
| Swain, S.L. 1981. Significance of Lyt phenotypes: Lyt2 antibodies block activation of T cells that recognize class I MHC antigens regardless of their function. Proc. Natl. Acad. Sci. U.S.A. 78:7101-7105. | |
| These articles describe the concepts and methods of fractionating T cell subsets on the basis of CD4 (L3T4) and CD8 (Lyt2) expression. | |
Did you know we publish 20-30 new protocols monthly? Stay informed! Sign up for NEW PROTOCOL ALERTS.
PUBLISH YOUR PROTOCOL on CurrentProtocols.com.
Read our editors' blog for news, commentaries, and the latest developments in methods in and out of the lab.
Tools & Calculators
Your Recently Viewed Protocols
- High‐Resolution Multi‐Contrast MRI of the Carotid Artery Wall for Evaluation of Atherosclerotic Plaques
- 3‐D Reconstruction of Neurons from Multichannel Confocal Laser Scanning Image Series
- Plug Flow Cytometry
- In Vivo Depletion of CD4‐ and CD8‐Specific T Cells
- Analysis of Expression Data: An Overview




Join the Conversation
Post new comment